James River Group Holdings, Inc. current report, 26 December 2023

Business Context and Reporting Period

This Form 8-K Current Report was filed by James River Group Holdings, Ltd. on December 26, 2023. The filing addresses the formalization of the separation of Terence M. McCafferty, President and Chief Executive Officer of the Company's Specialty Admitted Insurance segment, who departed effective December 2, 2023.

Key Financial Metrics

The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed relates to the executive separation agreement:

  • Expense Reimbursement: $110,000 payable to the departing executive.

Material Changes

The primary material change reported is the execution of a Separation and Release Agreement with Mr. McCafferty. Key terms include:

  • Short-Term Incentive Plan (STIP): Mr. McCafferty is entitled to a pro-rated cash incentive award based on 2023 fiscal year performance goals.
  • Long-Term Incentive Plan (LTIP):
    • Pro-rata settlement of the 2023 performance-based LTIP award, determined by actual performance over the three-year period ending December 31, 2025.
    • Settlement of service-based Restricted Stock Units (RSUs) awarded in 2023 that would have vested on the next annual vesting date, to be settled within 30 days of the separation date.
    • Forfeiture of any remaining service-based RSUs.
  • Legal Status: The agreement includes mutual general releases and is subject to a seven-day revocation period before becoming effective.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, outlook, or management commentary regarding future financial performance. The primary contingency noted is the seven-day revocation period during which Mr. McCafferty may revoke the Separation Agreement, preventing it from becoming effective or enforceable.

Investor Verification Checklist

  • Verify the final payout amounts for the STIP and LTIP once the 2023 performance goals and the 2025 performance period are finalized.
  • Confirm whether the seven-day revocation period has elapsed and the agreement is now legally binding.
  • Review subsequent filings for the appointment of a successor to the Specialty Admitted Insurance segment leadership.
  • Check for any impact on the Company's executive compensation expense in the next quarterly report.